Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation

Bibliographic Details
Main Authors: Awwad A. Radwan, Fars Alanazi, Abdullah Al-Dhfyan
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11020408/?tool=EBI
_version_ 1797198587694678016
author Awwad A. Radwan
Fars Alanazi
Abdullah Al-Dhfyan
author_facet Awwad A. Radwan
Fars Alanazi
Abdullah Al-Dhfyan
author_sort Awwad A. Radwan
collection DOAJ
first_indexed 2024-04-24T07:02:14Z
format Article
id doaj.art-9b4c4f482a1e4f92af807a4add907568
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-24T07:02:14Z
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-9b4c4f482a1e4f92af807a4add9075682024-04-22T05:32:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-01194Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluationAwwad A. RadwanFars AlanaziAbdullah Al-Dhfyanhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11020408/?tool=EBI
spellingShingle Awwad A. Radwan
Fars Alanazi
Abdullah Al-Dhfyan
Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation
PLoS ONE
title Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation
title_full Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation
title_fullStr Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation
title_full_unstemmed Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation
title_short Bioinformatics-driven discovery of novel EGFR kinase inhibitors as anti-cancer therapeutics: In silico screening and in vitro evaluation
title_sort bioinformatics driven discovery of novel egfr kinase inhibitors as anti cancer therapeutics in silico screening and in vitro evaluation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11020408/?tool=EBI
work_keys_str_mv AT awwadaradwan bioinformaticsdrivendiscoveryofnovelegfrkinaseinhibitorsasanticancertherapeuticsinsilicoscreeningandinvitroevaluation
AT farsalanazi bioinformaticsdrivendiscoveryofnovelegfrkinaseinhibitorsasanticancertherapeuticsinsilicoscreeningandinvitroevaluation
AT abdullahaldhfyan bioinformaticsdrivendiscoveryofnovelegfrkinaseinhibitorsasanticancertherapeuticsinsilicoscreeningandinvitroevaluation